Evidence map›Paper›PMID 31277229›Full record

ArticlePolymers2019

Isolation and Characterization of Nanocellulose with a Novel Shape from Walnut (

Dingyuan Zheng, Yangyang Zhang, Yunfeng Guo, Jinquan Yue

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 175 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dingyuan ZhengCollege of Material Science and Engineering, Northeast Forestry University, Harbin 150040, China.ORCID 0000-0001-5138-5949
Yangyang ZhangCollege of Material Science and Engineering, Northeast Forestry University, Harbin 150040, China.
Yunfeng GuoCollege of Material Science and Engineering, Northeast Forestry University, Harbin 150040, China.
Jinquan YueCollege of Material Science and Engineering, Northeast Forestry University, Harbin 150040, China. yuejinq@163.com.ORCID 0000-0002-8275-787X
Northeast Forestry University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, walnut shell (WS) was utilized as the raw material for the production of purified cellulose. The production technique involves multiple treatments, including alkaline treatment and bleaching. Furthermore, two nanocellulose materials were derived from WS by 2,2,6,6-tetramethylpiperidine-1-oxyl radical (TEMPO) oxidation and sulfuric acid hydrolysis, demonstrating the broad applicability and value of walnuts. The micromorphologies, crystalline structures, chemical functional groups, and thermal stabilities of the nanocellulose obtained via TEMPO oxidation and sulfuric acid hydrolysis (TNC and SNC, respectively) were comprehensively characterized. The TNC exhibited an irregular block structure, whereas the SNC was rectangular in shape, with a length of 55-82 nm and a width of 49-81 nm. These observations are expected to provide insight into the potential of utilizing WSs as the raw material for preparing nanocellulose, which could address the problems of the low-valued utilization of walnuts and pollution because of unused WSs.

Indexed as

nanocellulosesulfuric acid hydrolysisTEMPO oxidationultrasonicationWalnut shell

Identifiers

PMID31277229
PMCPMC6680793
OpenAlexW2954183680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.